Psychiatry and Neurology, Neurology · Boca Raton, FL
NPI
1023059169
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
951 NW 13th St, Bldg 5-E
Boca Raton, FL, 33486
Phone (561) 392-1818
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
4,869 services
Medicare patients, 2024
361
Average age 78
Drug cost, 2024
$3.3M
2,232 prescriptions
Company payments, 2025
$803K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stuart H Isaacson was code 99215 (office e&m - established), 593 times for 207 patients. In total Stuart H Isaacson billed 4,869 services in 22 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 593 | 207 | $139.79 | $83K |
| 99443 Telephone Services | Office | 442 | 204 | $101.37 | $45K |
| 11105 Skin Biopsy | Office | 153 | 77 | $46.97 | $7,187 |
| 99214 Office E&M - Established | Office | 151 | 108 | $95.23 | $14K |
| 11104 Skin Biopsy | Office | 77 | 77 | $97.59 | $7,515 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 54 | 41 | $13.18 | $712 |
| 99442 Telephone Services | Office | 46 | 38 | $69.51 | $3,197 |
| 99213 Office E&M - Established | Office | 40 | 37 | $73.07 | $2,923 |
By year: 2022 $224K for 11,946 services; 2023 $167K for 8,372 services; 2024 $183K for 4,869 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stuart H Isaacson prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 530 prescriptions and refills. In total Stuart H Isaacson wrote 2,232 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 530 | 1,438 | 182 | $24K |
| Rytary Carbidopa/Levodopa | 220 | 477 | 46 | $250K |
| Nuplazid Pimavanserin Tartrate | 211 | 299 | 38 | $1.4M |
| Rasagiline Mesylate Generic | 149 | 340 | 38 | $17K |
| Ongentys Opicapone | 106 | 231 | 25 | $152K |
| Gocovri Amantadine Hcl | 103 | 158 | 16 | $370K |
| Rivastigmine Generic | 96 | 204 | 28 | $28K |
| Donepezil Hcl Generic | 72 | 202 | 27 | $1,649 |
| Nourianz Istradefylline | 69 | 145 | 21 | $268K |
| Crexont Carbidopa/Levodopa | 63 | 117 | 26 | $45K |
| Sertraline Hcl Generic | 53 | 138 | 18 | $667 |
| Memantine Hcl Generic | 43 | 105 | 15 | $1,448 |
| Neupro Rotigotine | 42 | 66 | 11 | $55K |
| Quetiapine Fumarate Generic | 41 | 83 | 17 | $838 |
| Midodrine Hcl Generic | 38 | 89 | Under 11 | $2,220 |
Brand drugs: 1,006 claims; generic drugs: 1,226 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stuart H Isaacson $803K ($572K in general payments such as food, travel and fees and $230K for research) from 22 companies. The largest payer was Amneal Pharmaceuticals LLC with $278K.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 29 | $278K |
| MDD US Operations, LLC | 146 | $212K |
| Neurocrine BioSciences, Inc. NBIX | 63 | $100K |
| Abbvie Inc. ABBV | 53 | $58K |
| Teva Pharmaceuticals USA, Inc. TEVA | 18 | $54K |
| ACADIA Pharmaceuticals Inc ACAD | 28 | $38K |
| Merz Pharmaceuticals, LLC | 13 | $26K |
| H. Lundbeck A S HLUN-A.CO | 4 | $22K |
| Genentech USA, Inc. ROG.SW | 6 | $7,208 |
| F. Hoffmann-La Roche AG ROG.SW | 1 | $2,900 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.